Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus escitalopram for depression in chronic hemodialysis patients
IRCT20210424051066N1Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of escitalopram and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Effectiveness of drugs based on Beck questionnaire. Started Mar 2020; status: completed.
02
Drugs
escitalopramsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20210424051066N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210424051066N1.